Generali Deutschland AG:企業の戦略・SWOT・財務情報

◆英語タイトル:Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4048
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Generali Deutschland AG – Strategy, SWOT and Corporate Finance Report
Summary

Generali Deutschland AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Generali Deutschland AG (Generali Deutschland), a subsidiary of Assicurazioni Generali S.p.A., is an insurance solutions holding company. The company, through its subsidiaries, offers a range of insurance and financial products and services to individual and corporate clients. The major products offered by the company includes life insurance, liability insurance, household insurance, motor insurance, accident insurance, travel insurance, home insurance and assets compensation plans. It also offers technical insurance, transport insurance, term life insurance, private liability insurance, health insurance, legal protection insurance, occupational disability protection and group insurance. Generali Deutschland ‘s major service offerings include insurance advisory services, online insurance services, retirement planning and solutions, financial planning services, actuarial services and claims settlement services. Generali Deutschland is headquartered in Munich, Germany.

The company reported gross written premium of EUR16,227 million during the fiscal year ended on December 31, 2016 (FY 2016), representing an decline of 8.6% over FY2015.

Scope

- Detailed information on Generali Deutschland AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Generali Deutschland AG in the form of a SWOT analysis
- An in-depth view of the business model of Generali Deutschland AG including a breakdown and examination of key business segments
- Intelligence on Generali Deutschland AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Generali Deutschland AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Generali Deutschland AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Generali Deutschland AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Generali Deutschland AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Generali Deutschland AG: Company Overview 9
Generali Deutschland AG: Overview and Key Facts 9
Generali Deutschland AG: Overview 9
Generali Deutschland AG: Key Facts 9
Generali Deutschland AG: Key Employees 10
Generali Deutschland AG: Key Employee Biographies 11
Generali Deutschland AG: Major Products and Services 13
Generali Deutschland AG: Company History 14
Generali Deutschland AG: Management Statement 17
Generali Deutschland AG: Locations and Subsidiaries 19
Generali Deutschland AG: Key Competitors 22
Generali Deutschland AG: Company Analysis 23
Generali Deutschland AG: Business Description 23
Generali Deutschland AG: SWOT Analysis 24
Generali Deutschland AG: SWOT Overview 24
Generali Deutschland AG: Strengths 24
Generali Deutschland AG: Weaknesses 25
Generali Deutschland AG: Opportunities 25
Generali Deutschland AG: Threats 26
Generali Deutschland AG: Corporate Financial Deals Activity 27
Generali Deutschland AG: Financial Deals Overview 27
Generali Deutschland AG: Top Deals 2014 – 2018YTD* 29
Generali Deutschland AG: Advisors 30
Generali Deutschland AG: Top Legal Advisors 30
Generali Deutschland AG: Top Financial Advisors 30
Generali Deutschland AG: Divestments 31
Generali Deutschland AG: Recent Developments 32
Generali Deutschland AG: News and Events Summary 32
Generali Deutschland AG: Business Expansion 34
Generali Deutschland AG: Business Reorganization 34
Generali Deutschland AG: Corporate Governance 35
Generali Deutschland AG: Financial Performance 35
Generali Deutschland AG: Strategy and Operations 36
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: Generali Deutschland AG: Key Facts
Table 2: Generali Deutschland AG: Key Employees
Table 3: Generali Deutschland AG: Locations and Subsidiaries
Table 4: Generali Deutschland AG: Key Competitors
Table 5: Generali Deutschland AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Generali Deutschland AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Generali Deutschland AG: Top Deals 2014 - 2018YTD*
Table 8: Generali Deutschland AG: Legal Advisor Ranking by Value (US$m)
Table 9: Generali Deutschland AG: Financial Advisor Ranking by Value (US$m)
Table 10: Generali Deutschland AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 11: Generali Deutschland AG: Divestments by Geography (2014 - YTD*2018)
Table 12: Generali Deutschland AG: News and Events Summary
Table 13: Generali Deutschland AG: Business Expansion
Table 14: Generali Deutschland AG: Business Reorganization
Table 15: Generali Deutschland AG: Corporate Governance
Table 16: Generali Deutschland AG: Financial Performance
Table 17: Generali Deutschland AG: Strategy and Operations

List of Figures
Figure 1: Generali Deutschland AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Generali Deutschland AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Generali Deutschland AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 4: Generali Deutschland AG: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Generali Deutschland AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bank of Taiwan:企業の戦略・SWOT・財務分析
    Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ovintiv Canada ULC:企業の戦略的SWOT分析
    Ovintiv Canada ULC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Galp Energia SGPS SA (GALP)-エネルギー分野:企業M&A・提携分析
    Summary Galp Energia SGPS S.A. (Galp Energia) is an integrated oil and natural gas company. It explores for, develops and produces crude oil and natural gas; refines crude oil and markets refined petroleum products. The company also imports, transports and distributes natural gas. It conducts the na …
  • PharmAthene Inc (PIP)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company’s products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bios …
  • Wilson Vale:企業の戦略・SWOT・財務情報
    Wilson Vale - Strategy, SWOT and Corporate Finance Report Summary Wilson Vale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Guernsey Electricity Ltd:企業の戦略的SWOT分析
    Guernsey Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kala Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company which focuses on nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase …
  • UCO Bank:戦略・SWOT・企業財務分析
    UCO Bank - Strategy, SWOT and Corporate Finance Report Summary UCO Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …
  • Guangzhou Institute of Biomedicine and Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that develops protocols for disease control and prevention. The institute conducts research in the areas of stem cell and regenerative medicine, chemical biology, immunology and infectious diseases, public health, a …
  • Roche Diagnostics Corp:企業のM&A・事業提携・投資動向
    Roche Diagnostics Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roche Diagnostics Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Alitalia – Societa Aerea Italiana S.p.A.:戦略・SWOT・企業財務分析
    Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Bridgford Foods Corporation:戦略・SWOT・企業財務分析
    Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mattress Firm Holding Corp.:企業のM&A・事業提携・投資動向
    Mattress Firm Holding Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mattress Firm Holding Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • VWR International LLC:医療機器:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務分析
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Caledonia Investments plc:企業の戦略・SWOT・財務情報
    Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report Summary Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Fagron NV (FAGR):企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆